Mohammad Najlah

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Pharmaceutics

Molecules (Basel, Switzerland)

Cancers

Nanomaterials (Basel, Switzerland)

Anglia Ruskin University, Faculty of Medical Science

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Anglia Ruskin University, Faculty of Medical Science Jun 01 2016

United Kingdom

Deputy Head of Department :: Medicine & Healthcare Science

Anglia Ruskin University, Faculty of Medical Science Jan 01 2016 - May 31 2016

United Kingdom

Acting Deputy Head of Department :: Medicine & Healthcare Science

Anglia Ruskin University Jan 01 2015 - May 31 2016

United Kingdom

Senior Lecturer, Course Leader for BSc (Hons) Pharmaceutical Science :: Medicine & Healthcare Science

Education History

University of Manchester

United Kingdom

PHD :: School of Pharmacy

Publications

Ibrahim Dumbuya, Ana Maria Pereira, Ibrahim Tolaymat, Adnan Al Dalaty, Basel Arafat, Matt Webster, Barbara K Pierscionek, Mouhamad Khoder, Mohammad Najlah
Exploring Disulfiram's Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy. Nanomaterials (Basel, Switzerland) 14 (13) (2024)
Niamh McCallum, Mohammad Najlah
The Anticancer Activity of Monosaccharides: Perspectives and Outlooks. Cancers 16 (16) (2024)
Niamh McCallum, Mohammad Najlah
The Anticancer Activity of Monosaccharides: Perspectives and Outlooks. Cancers 16 (16) (2024)
Ibrahim Dumbuya, Ana Maria Pereira, Ibrahim Tolaymat, Adnan Al Dalaty, Basel Arafat, Matt Webster, Barbara K Pierscionek, Mouhamad Khoder, Mohammad Najlah
Exploring Disulfiram's Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy. Nanomaterials (Basel, Switzerland) 14 (13) (2024)
Ayşe Kaya, Basel Arafat, Havovi Chichger, Ibrahim Tolaymat, Barbara K Pierscionek, Mouhamad Khoder, Mohammad Najlah
Preparation and Characterisation of Zinc Diethyldithiocarbamate-Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment. Pharmaceutics 16 (1) (2023)
Ayşe Kaya, Basel Arafat, Havovi Chichger, Ibrahim Tolaymat, Barbara K Pierscionek, Mouhamad Khoder, Mohammad Najlah
Preparation and Characterisation of Zinc Diethyldithiocarbamate-Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment. Pharmaceutics 16 (1) (2023)
Ayşe Kaya, Basel Arafat, Havovi Chichger, Ibrahim Tolaymat, Barbara K Pierscionek, Mouhamad Khoder, Mohammad Najlah
Preparation and Characterisation of Zinc Diethyldithiocarbamate-Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment. Pharmaceutics 16 (1) (2023)
Vinodh Kannappan, Ying Liu, Zhipeng Wang, Karim Azar, Sathishkumar Kurusamy, Rajagopal S Kilari, Angel L Armesilla, Mark R Morris, Mohammad Najlah, Peng Liu, Xiu-Wu Bian, Weiguang Wang
PLGA-Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo. Molecular cancer therapeutics 21 (8) (2022)
Ana Maria Pereira, Ayse Kaya, Dan Alves, Niusha Ansari-Fard, Ibrahim Tolaymat, Basel Arafat, Mohammad Najlah
Preparation and Characterization of Disulfiram and Beta Cyclodextrin Inclusion Complexes for Potential Application in the Treatment of SARS-CoV-2 via Nebulization. Molecules (Basel, Switzerland) 27 (17) (2022)
Barbara Helena Barcaro Machado, Jufen Zhang, James Frame, Mohammad Najlah
Treatment of Scars with Laser-Assisted Delivery of Growth Factors and Vitamin C: A Comparative, Randomised, Double-blind, Early Clinical Trial. Aesthetic plastic surgery 45 (5) (2021)
Layan Dahabra, Grace Broadberry, Adam LeGresley, Mohammad Najlah, Mouhamad Khoder
Sunscreens Containing Cyclodextrin Inclusion Complexes for Enhanced Efficiency: A Strategy for Skin Cancer Prevention. Molecules (Basel, Switzerland) 26 (6) (2021)
Mohammad Najlah
Drug repurposing supported by nanotechnology: a promising strategy to fight cancer. Therapeutic delivery 12 (4) (2021)
Ammar Said Suliman, Mouhamad Khoder, Ibrahim Tolaymat, Matt Webster, Raid G Alany, Weiguang Wang, Abdelbary Elhissi, Mohammad Najlah
Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines. Pharmaceutics 13 (1) (2021)
Barbara Helena Barcaro Machado, James Frame, Jufen Zhang, Mohammad Najlah
Comparative Study on the Outcome of Periorbital Wrinkles Treated with Laser-Assisted Delivery of Vitamin C or Vitamin C Plus Growth Factors: A Randomized, Double-blind, Clinical Trial. Aesthetic plastic surgery 45 (3) (2020)
Mohammad Najlah, Ammar Said Suliman, Ibrahim Tolaymat, Sathishkumar Kurusamy, Vinodh Kannappan, Abdelbary M A Elhissi, Weiguang Wang
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment. Pharmaceutics 11 (11) (2019)
Mohammad Najlah, Sally Freeman, Mouhamad Khoder, David Attwood, Antony D'Emanuele
In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates. Molecules (Basel, Switzerland) 22 (10) (2017)

Mohammad Najlah.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad Najlah